AIP and metabolic syndrome: After excluding participants with baseline dyslipidemia, the AIP consistently emerged as the most robust marker for normoglycemia, with the lowest OR value after adjusting for all variables (model 3) (OR 0.708, 95% CI: 0.551–0.910), and AIP demonstrated the strongest predictive ability (Supplementary Tables S3, S4).